Alright, lets begin. 1) "counseled by several industry

New Post Public Reply Private Reply Replies (3) Message Board
longboardsurfer90210
Alright, lets begin.

1) "counseled by several industry veterans" What industry veterans? He needs counseling?

2) "chief among them being patience and faith." Part of the counseling he received was an industry veteran telling him to be patient and that it takes time? Really?

3) "current team." You mean, whats left of the current team?

4) "while also delivering significant value to a healthcare system stretched to its financial capacity.” Yeah, that’s what he is concerned about.

5) "near-term liquidity events." Ahh- the ever so elusive near term event.

6) "the Board of Directors has given management the mandate to accelerate our partnering initiatives in order to acquire the resources necessary to move the rest of the portfolio forward. " Oh, so the reason we don’t have any partners for ANY OF OUR ASSETS is because management never forced us to consider them?

7) "while preserving and/or transferring value to our shareholders along the way." This statement needs zero comment.

8) " transact on either ESS or Eltoprazine in order to further refine the Company’s profile into a regenerative medicine company (ESS + MANF + Phenoguard) or a neurology company (Eltoprazine + MANF + Phenoguard)" In other words, we have no idea who we are or what we are about. And what the hell does “transact on” mean?

9) "could provide a pipeline for a very valuable standalone public company." There is the elusive “could provide” but hasn’t yet, but keep holding your breath.

10) "conditions in the market for our common shares rapidly deteriorated in the third quarter." -It just gets better. Conditions in the market didn’t deteriorate the value, getting into bed with toxic financiers did. This was the one I was REALLY hoping to not hear. The CEO is directly responsible for the deterioration of the share price….PERIOD! Nice try Gerald, by passing the buck.

11) "value appreciation of our common stock could potentially occur." – Again, been hearing that for the last 3 years.

12) "As we evaluate potential business development opportunities." What potential business development opportunities do they have to evaluate? Been hearing this one forever. Must be attached to those ever elusive NDA’s.

13) "we are working behind the scenes to understand." – In other words, “ we don’t know what’s going on.” That’s a great place to be after destroying all of the long term shareholders value.

14) "begin evaluating Phase 3 development plans for adult ADHD as well as Phase 2 development plans for Alzheimer’s aggression." - “Begin evaluating”? Means nothing.

15) "Given the recent uptick in interest in Alzheimer’s therapies" – Recent? The interest in Alzheimers therapies is not “recent”.

16) "we are especially excited about the potential to develop Eltoprazine in this area" – Ahhhhh. The overly used “especially excited”.

17) "made good progress on the commercial launch plan for MSPrecise® at a meeting we held in Dallas, TX." Ahhhh, the overly used “made good progress” statement. Meeting with who? Who wants MS Precise? We have had it for how long?

18) " continuing to evaluate the next set of studies to further enhance LymPro’s value - Ahhhh, the “continuing to evaluate” statement. I thought this thing was going to be generating revenue so that we would not have to dilute. Besides, “a reverse split may not even be necessary.”

19) "and will forego the option agreement with Georgetown University." – Hence, “we have no more money to continue with our option agreement.” I thought this was necessary to strengthen the diagnostics suite and increase the accuracy of the Lympro test?

20) "that we recently completely enrollment." - A fricken spelling error? Does not anyone re-read these things before they post them?

21) "we believe we have sufficient critical mass." – And again the “we believe”. Obviously the market does not share your belief.

22) "are now focused on the CLIA launch plans for these products. – I thought this was going to happen ages ago. “Now focused”?

23) "We remain on track to transact on the diagnostics division"- Really? Remain on track? That’s a subjective term. For when? 2030?

24) "as a key time to potentially make public announcements of definitive agreements." – This is the best. “Potentially make” and “definitive agreements” used in the same sentence.

25) "we believe the sheer strength of our portfolio will allow the Company to overcome the challenges we face." – Yeah, its doing such a good job so far. The only challenge we need to overcome is to figure out how to get someone in there that knows what they are doing.

26) "we believe we have a strong execution plan, with achievable milestones" – “Believe”? How about “know”? Also, heard this many times in the past.

27)"We believe the support of our shareholders at this time in our corporate history is paramount." – This one takes the trophy! And we should support you because? Based on this piece of crap blog? Based on all of things you have claimed that never happened? Your stellar communication? It’s as if he does not even realize that many of us are down 90% +. He has given us zero reason to support his, what I now consider, delusional visions.

28) "working with our team" – what team? Who is left?

I am sure there is stuff I missed, but if there was ever a blog that was unapologetic and filled with uncertainty and just a repeat of previous “ramblings”, this was it. Did ya notice that the amount of timelines that are missing compared with previous posts? Don't know about you, but that gave me zero confidence that things are going to turn out well. Reverse split into oblivion is my prediction. What say you?

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 7

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
Supply Maverick Simplifies Global Shipping Processes

Updated Category News Views 5

Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Tequila Don Julio 1942 and Peggy Gou's Unique Collaboration

Updated Category News Views 420

Tequila Don Julio 1942 Unveils Exclusive Collaboration with Peggy Gou Tequila Don Julio 1942, renowned as the world's leading tequila brand, has launched a remarkable collaboration with DJ and style icon Peggy Gou. This special edition bottle, known as Don Julio 194? (Gou), is not only a representation of exquisite taste but also pays homage to the brand's deep-rooted...

Continue Reading
Investigation into MoonLake Immunotherapeutics Sparks Concern

Updated Category News Views 272

Investigation Into MoonLake Immunotherapeutics MoonLake Immunotherapeutics, a clinical stage biotechnology company, is making headlines due to an investigation initiated by a leading securities law firm. Investors are understandably worried after the company's stock price plummeted significantly following disappointing results from a critical drug trial. The VELA Trials...

Continue Reading
Cholesterol Testing Market Set to Experience Robust Growth

Updated Category News Views 228

Overview of the Cholesterol Testing Market The cholesterol testing market plays a crucial role in healthcare, being key for assessing heart health. It involves tests like lipid panels that measure various types of fats in the blood. Primarily, these tests evaluate total cholesterol, low-density lipoprotein (LDL or 'bad' cholesterol), high-density lipoprotein (HDL or...

Continue Reading
Webus International Clarifies Partnership with Air China Services

Updated Category News Views 147

Webus International's Clarification on Cooperation with Air China HANGZHOU, China – Webus International Limited (NASDAQ: WETO) is at the forefront of providing exceptional mobility and travel services globally. Recently, the company decided to clarify its recent announcement titled “WETO Signs Strategic Partnership with Air China,” as the initial wording could have...

Continue Reading
Coinbase-Backed Startup Secures $15 Million for Prediction Platform

Updated Category News Views 295

New Venture Emerges in Prediction Markets A former executive has announced a significant funding milestone — a $15 million seed round aimed at establishing a platform called The Clearing Company. This innovative startup intends to carve a niche in the prediction market sector. Leading the Charge with Backing from Industry Giants The funding round was spearheaded by...

Continue Reading